G.A. Thomas

591 total citations
20 papers, 487 citations indexed

About

G.A. Thomas is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, G.A. Thomas has authored 20 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in G.A. Thomas's work include Thyroid Cancer Diagnosis and Treatment (5 papers), Genetic factors in colorectal cancer (3 papers) and Thyroid Disorders and Treatments (3 papers). G.A. Thomas is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (5 papers), Genetic factors in colorectal cancer (3 papers) and Thyroid Disorders and Treatments (3 papers). G.A. Thomas collaborates with scholars based in United Kingdom, France and Australia. G.A. Thomas's co-authors include E. D. Williams, Ian S. Fraser, David W. Williams, Siobhán Rooney, Gemma Cummins, Richard C. Hamelin, Elizabeth D. Williams, Margery A. Barrand, Youjun Li and M Poisson and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

G.A. Thomas

20 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.A. Thomas United Kingdom 12 184 178 150 88 77 20 487
John T. Chow United States 8 201 1.1× 264 1.5× 79 0.5× 189 2.1× 122 1.6× 10 599
Paul V. Newcomb United Kingdom 11 157 0.9× 281 1.6× 304 2.0× 79 0.9× 198 2.6× 13 597
Takesada Mori Japan 14 332 1.8× 361 2.0× 130 0.9× 215 2.4× 88 1.1× 29 799
Iwona Lewy‐Trenda Poland 13 99 0.5× 183 1.0× 68 0.5× 53 0.6× 111 1.4× 44 454
Linda Henry United Kingdom 6 208 1.1× 123 0.7× 54 0.4× 58 0.7× 108 1.4× 13 524
Kartik Viswanathan United States 11 186 1.0× 109 0.6× 51 0.3× 145 1.6× 74 1.0× 28 423
AA Colletta United Kingdom 9 192 1.0× 282 1.6× 72 0.5× 43 0.5× 90 1.2× 12 614
Jose R. Ramı́rez Spain 12 91 0.5× 283 1.6× 25 0.2× 82 0.9× 87 1.1× 13 580
Cuizhen Li United States 12 122 0.7× 321 1.8× 38 0.3× 133 1.5× 175 2.3× 20 627
Haitao Zheng China 17 78 0.4× 316 1.8× 189 1.3× 208 2.4× 232 3.0× 58 724

Countries citing papers authored by G.A. Thomas

Since Specialization
Citations

This map shows the geographic impact of G.A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.A. Thomas more than expected).

Fields of papers citing papers by G.A. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.A. Thomas. The network helps show where G.A. Thomas may publish in the future.

Co-authorship network of co-authors of G.A. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of G.A. Thomas. A scholar is included among the top collaborators of G.A. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.A. Thomas. G.A. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Тronko, М.D., et al.. (2014). Thyroid cancer in Ukraine after Chernobyl : dosimetry, epidemiology, pathology, molecular biology. Medical Entomology and Zoology. 15 indexed citations
2.
Väänänen, Antti, et al.. (2006). Mmp-8 expression in females correlates with the improved survival of tongue cancer. Journal of Oral Pathology and Medicine. 35(7). 429–429. 1 indexed citations
3.
Powell, Ned, Jeffrey H. Grubb, S.J. Jeremiah, et al.. (2005). Investigation of Loss of Heterozygosity and SNP Frequencies in the RET Gene in Papillary Thyroid Carcinoma. Thyroid. 15(2). 100–104. 15 indexed citations
4.
Jacob, Rojymon, et al.. (2003). Squamous carcinoma in an oesophageal foregut cyst. British Journal of Radiology. 76(905). 343–346. 9 indexed citations
5.
Thomas, G.A., et al.. (2002). Analysis of the Ki‐67 antigen at the invasive tumour front of human oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 31(10). 598–604. 77 indexed citations
6.
Thomas, G.A.. (2001). Chernobyl Thyroid Tumor Bank. The Journal of Clinical Endocrinology & Metabolism. 86(3). 1428–1428. 1 indexed citations
7.
Kuraguchi, Mari, Helen Cook, Elizabeth D. Williams, & G.A. Thomas. (2001). Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice. The Journal of Pathology. 193(4). 517–521. 16 indexed citations
8.
Koppang, Erling O., G.A. Thomas, K. Rönningen, & Charles McL. Press. (1998). Expression of insulin-like growth factor-I in the gastrointestinal tract of Atlantic salmon (Salmo salar L.). Fish Physiology and Biochemistry. 18(2). 167–175. 7 indexed citations
9.
Kuraguchi, Mari, G.A. Thomas, & E. D. Williams. (1997). Somatic mutation of the glucose-6-phosphate dehydrogenase (g6pd) gene in colonic stem cells and crypt restricted loss of G6PD activity. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 379(1). 69–75. 9 indexed citations
11.
Muzeau, Françoise, Fléjou Jf, F Potet, et al.. (1996). [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].. PubMed. 20(5). 430–7. 20 indexed citations
12.
Li, Youjun, Khê Hoang‐Xuan, J. Delattre, et al.. (1995). Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.. PubMed. 11(3). 597–600. 46 indexed citations
13.
Thomas, G.A., et al.. (1994). Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. European Journal of Cancer. 30(11). 1705–1709. 48 indexed citations
14.
Thomas, G.A., Howard Davies, & Elizabeth D. Williams. (1993). Demonstration of mRNA using digoxigenin labelled oligonucleotide probes for in situ hybridisation in formamide free conditions.. Journal of Clinical Pathology. 46(2). 171–174. 18 indexed citations
15.
Thomas, G.A. & E. D. Williams. (1992). Production of thyroid tumours in mice by demethylating agents. Carcinogenesis. 13(6). 1039–1042. 19 indexed citations
16.
Thomas, G.A., et al.. (1992). Oestrogen receptor protein and mRNA in adenocarcinoma of the uterine cervix. British Journal of Cancer. 66(6). 1150–1154. 9 indexed citations
17.
Thomas, G.A. & E. D. Williams. (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 248(2). 357–370. 36 indexed citations
18.
Thomas, G.A., David W. Williams, & E. D. Williams. (1991). Reversibility of the malignant phenotype in monoclonal tumours in the mouse. British Journal of Cancer. 63(2). 213–216. 10 indexed citations
19.
Thomas, G.A., David W. Williams, & E. D. Williams. (1989). The clonal origin of thyroid nodules and adenomas.. PubMed. 134(1). 141–7. 62 indexed citations
20.
Thomas, G.A. & E. D. Williams. (1988). 10 Aetiology of simple goitre. Baillière s Clinical Endocrinology and Metabolism. 2(3). 703–718. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026